195 related articles for article (PubMed ID: 24007767)
21. Understanding Perceived Barriers to Colposcopy Follow-Up Among Underserved Women at an Urban Teaching Hospital: A Qualitative Study.
Kulkarni A; Glynn S; Gamble CR; Shen MJ; Cantillo E; Frey MK; Holcomb KM; Safford MM; Chapman-Davis E
J Low Genit Tract Dis; 2023 Jan; 27(1):87-92. PubMed ID: 36074132
[TBL] [Abstract][Full Text] [Related]
22. The effect of educational brochures on knowledge and emotional distress in women with abnormal Papanicolaou smears.
Stewart DE; Lickrish GM; Sierra S; Parkin H
Obstet Gynecol; 1993 Feb; 81(2):280-2. PubMed ID: 8423964
[TBL] [Abstract][Full Text] [Related]
23. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
24. Intervention to improve follow-up for abnormal Papanicolaou tests: a randomized clinical trial.
Breitkopf CR; Dawson L; Grady JJ; Breitkopf DM; Nelson-Becker C; Snyder RR
Health Psychol; 2014 Apr; 33(4):307-316. PubMed ID: 23730719
[TBL] [Abstract][Full Text] [Related]
25. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
Momberg M; Botha MH; Van der Merwe FH; Moodley J
BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
[TBL] [Abstract][Full Text] [Related]
26. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic.
Lavin C; Goodman E; Perlman S; Kelly LS; Emans SJ
J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):141-5. PubMed ID: 9288658
[TBL] [Abstract][Full Text] [Related]
27. Predicting nonattendance for colposcopy clinic follow-up after referral for an abnormal Pap smear.
Kavanagh AM; Simpson JM
Aust N Z J Public Health; 1996 Jun; 20(3):266-71. PubMed ID: 8768416
[TBL] [Abstract][Full Text] [Related]
28. Understanding factors related to women's adherence to colposcopy.
Pritham UA; Brigdon A; Jones M
Nurs Womens Health; 2014; 18(5):402-12. PubMed ID: 25316540
[TBL] [Abstract][Full Text] [Related]
29. Comparative effectiveness of two outreach strategies for cervical cancer screening.
Bowles EJ; Gao H; Brandzel S; Bradford SC; Buist DS
Prev Med; 2016 May; 86():19-27. PubMed ID: 26820221
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial.
Brewster WR; Hubbell FA; Largent J; Ziogas A; Lin F; Howe S; Ganiats TG; Anton-Culver H; Manetta A
JAMA; 2005 Nov; 294(17):2182-7. PubMed ID: 16264159
[TBL] [Abstract][Full Text] [Related]
31. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R
J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754
[TBL] [Abstract][Full Text] [Related]
32. How reminders given to patients and physicians affected pap smear use in a health maintenance organization: results of a randomized controlled trial.
Burack RC; Gimotty PA; George J; McBride S; Moncrease A; Simon MS; Dews P; Coombs J
Cancer; 1998 Jun; 82(12):2391-400. PubMed ID: 9635532
[TBL] [Abstract][Full Text] [Related]
33. Can tailored interventions increase mammography use among HMO women?
Lipkus IM; Rimer BK; Halabi S; Strigo TS
Am J Prev Med; 2000 Jan; 18(1):1-10. PubMed ID: 10808977
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancer risk and screening among women seeking assistance with basic needs.
Kuroki LM; Massad LS; Woolfolk C; Thompson T; McQueen A; Kreuter MW
Am J Obstet Gynecol; 2021 Apr; 224(4):368.e1-368.e8. PubMed ID: 33316278
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with time to colposcopy after abnormal Pap testing in HIV-infected women.
Baranoski AS; Stier EA
J Womens Health (Larchmt); 2012 Apr; 21(4):418-24. PubMed ID: 22141453
[TBL] [Abstract][Full Text] [Related]
36. Adherence to recommendations for follow-up to abnormal Pap tests.
Eggleston KS; Coker AL; Luchok KJ; Meyer TE
Obstet Gynecol; 2007 Jun; 109(6):1332-41. PubMed ID: 17540805
[TBL] [Abstract][Full Text] [Related]
37. Increasing cervical cancer screening for a multiethnic population of women in South Texas.
Fornos LB; Urbansky KA; Villarreal R
J Cancer Educ; 2014 Mar; 29(1):62-8. PubMed ID: 24170274
[TBL] [Abstract][Full Text] [Related]
38. Health literacy as a predictor of follow-up after an abnormal Pap smear: a prospective study.
Lindau ST; Basu A; Leitsch SA
J Gen Intern Med; 2006 Aug; 21(8):829-34. PubMed ID: 16881942
[TBL] [Abstract][Full Text] [Related]
39. Abnormal Pap smear follow-up in a high-risk population.
Engelstad LP; Stewart SL; Nguyen BH; Bedeian KL; Rubin MM; Pasick RJ; Hiatt RA
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1015-20. PubMed ID: 11588126
[TBL] [Abstract][Full Text] [Related]
40. The effectiveness of a community outreach intervention to improve follow-up among underserved women at highest risk for cervical cancer.
Engelstad LP; Stewart S; Otero-Sabogal R; Leung MS; Davis PI; Pasick RJ
Prev Med; 2005; 41(3-4):741-8. PubMed ID: 16125761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
